Buy & Sell Marsh & McLennan Companies, Inc. (MRSH) – Marsh & McLennan Companies, Inc. Price Today
Aura AI Summary
Key Stats
- $78.72BMarket Cap
- FinancialsSector
- -13.47%3M Drawdown
- $99.56BEnterprise Value
- 2.2%Dividend Yield
- 0% Buy | 100% SellTrading Activity
- 99 daysTypical Hold Time
Marsh & McLennan Companies, Inc. (MRSH) is currently valued at a market capitalization of $78.72B, with an enterprise value of $99.56B. Over the past 52 weeks, Marsh & McLennan Companies, Inc. has traded between a low of $161.58 and a high of $234.86, highlighting its annual price range. Over the past three months, Marsh & McLennan Companies, Inc. has recorded a drawdown of -13.47%, reflecting recent price volatility. Marsh & McLennan Companies, Inc. offers a dividend yield of 2.2%, with the most recent dividend of $0.90 paid on 09 Apr 26. On average, investors hold Marsh & McLennan Companies, Inc. for approximately 99 days, indicating typical investor behavior on the platform.
About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Most Recent News
NevGold upsizes financing to C$42M, advancing US antimony-gold project with near-term production plans.
NevGold Corp. has increased its brokered private placement financing from C$25 million to over C$42 million due to strong institutional demand. The Vancouver-based junior miner is developing the Limousine Butte gold-antimony project in Nevada, target...
Quantum Cyber secures exclusive drone tech license amid $55B US drone warfare budget boost
Quantum Cyber has secured an exclusive license for BP United's autonomous drone technology, including a sky defense platform capable of over 25 km range and fully autonomous operations. This move positions Quantum Cyber to capitalize on the Trump adm...
Corbus Pharmaceuticals to present at RBC and Jefferies healthcare conferences in May and June 2026
Corbus Pharmaceuticals Holdings, a clinical-stage biotech company focused on oncology and obesity therapies, announced CEO Yuval Cohen will present corporate updates and meet investors at two major healthcare conferences in New York: the RBC Capital ...